Rachel Beatty
Papers
3
Total Citations
94
H-Index
3
About
Rachel Beatty is pioneering the intersection of soft robotics and implantable medicine, with a focus on overcoming the body’s foreign body response (FBR) to extend therapeutic efficacy. Her major contributions center on developing dynamic, soft robotic implants that actively adapt to fibrotic capsule formation—a key barrier to long-term drug delivery. In her highly cited 2022 work (43 citations), she demonstrated that dynamic actuation enhances molecular transport and extends the functional lifespan of implantable devices. Her 2023 paper (40 citations) introduced a FibroSensing Dynamic Soft Robot that autonomously senses and responds to fibrotic encapsulation, enabling sustained, tunable drug release. Most recently, in 2024, Beatty expanded her impact into cardiovascular research with a soft robotic platform for progressive and reversible aortic constriction in small-animal models, offering unprecedented control over cardiac remodeling studies. With over 90 citations across her top papers, Beatty’s work is reshaping how we design implants that work with the body, not against it. Her innovations hold promise for chronic disease management, from diabetes to heart failure, and position her as a rising leader in bio-inspired medical device engineering.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3